CMS ups hospital outpatient rates 2.6%, expands site-neutral payments in 2026: 14 notes
(By Laura Dyrda and Alan Condon for Becker’s Hospital Review) CMS on Nov. 21 finalized its Hospital Outpatient Prospective Payment
Read More
Health Care Finance
Chart Reviews Increase Payments to Medicare Advantage Insurers for 1 in 6 Enrollees
(Authors: Jeannie Fuglesten Biniek, Nolan Sroczynski, and Tricia Neuman for The Kaiser Family Foundation Published: Nov 20, 2025) Federal payments
Read MoreAfter Series of Denials, His Insurer Approved Doctor-Recommended Cancer Care. It Was Too Late.
(By Lauren Sausser for KFF Health News) For nearly three years, Eric Tennant endured chemotherapy infusions, rounds of radiation, biopsies,
Read MoreEmployers could grapple with +$18.5K in health insurance costs per person in 2026
(By: Elizabeth Casolo for Becker’s Hospital Review) Employers can expect a 6.7% increase in total health benefit costs in 2026
Read MoreComplaints About Gaps in Medicare Advantage Networks Are Common. Federal Enforcement Is Rare.
(By Susan Jaffe for KFF Health News) Along with the occasional aches and pains, growing older can bring surprise setbacks
Read More5 things to know about Medicaid’s administrative burdens
(By: Elizabeth Casolo for Becker’s Hospital Review) A recent study from St. Louis-based Washington University assessed administrative burdens that low-wage
Read MoreMedicare Beneficiaries Are Not Insulated from Affordability Challenges As Part B Premiums Rise in 2026
(By Tricia Neuman for The Kaiser Family Foundation published Nov 17, 2025) Last week, the Centers for Medicare & Medicaid
Read MoreHouse Republicans weigh sending ACA dollars to consumers
(By: Elizabeth Casolo for Becker’s Hospital Review) Republicans on the House Ways and Means Committee are considering a bill that
Read MoreVA to begin copayments for whole health well-being services
(Source – news.va.gov) Starting Oct. 1, 2025, VA will update its billing practices for Whole Health well-being services to ensure
Read MoreFDA’s Plan To Boost Biosimilar Drugs Could Stall at the Patent Office
(By Arthur Allen for KFF Health News) While the FDA is streamlining regulation of copycat versions of the expensive drugs
Read More